ReviewNature communications2025
A Latin American perspective on microbiome research.
Review in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Microbiome and One Health in GCC countries: current status, research gaps, and future directions.Frontiers in microbiology · 2026Pooled it
- Fecal microbiota transplantation in obesity: a comprehensive overview from basic research to clinical application.Frontiers in microbiology · 2026Pooled it
- Advocating for return-of-results to participants in microbiome research.Nature microbiology · 2026Article
- Research trends on autoimmune liver diseases and gut microbiota (1989-2025): a bibliometric and visualization analysis based on the web of science core collection database.Frontiers in immunology · 2026Article
- Supplementation with abioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The human gut microbiome plays a crucial role in human health, adapting and responding to changes in diet, environment, and lifestyle. However, current microbiome research is heavily biased toward high-income countries, leaving regions such as Latin America and the Caribbean (LAC) severely underrepresented. This imbalance limits our global understanding of microbial diversity and hinders the development of region-specific health interventions. In this Perspective, we discuss how LAC offers an exceptional opportunity for microbiome studies due to its unique ethnic diversity, rapid urbanization, distinct dietary traditions, and dual burden of infectious and chronic diseases. We highlight key findings from regional microbiome research, emphasizing the high diversity of ancestral microbial communities and the rapid shifts occurring in response to urbanization and globalization. To address existing disparities, we also introduce the Latinbiota Consortium, a collaborative network formed to strengthen local scientific capacity, ensure ethical and equitable research practices, promote data sovereignty, and foster inclusive participation by LAC researchers within global microbiome science. Through strategic investment and international collaboration, Latinbiota aims to preserve microbial diversity and ensure equitable participation in global microbiome science.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.